(2023). In Vitro and In Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine against Human Immunodeficiency Virus 1 (HIV-1).
Chicago Style (17th ed.) CitationIn Vitro and In Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine Against Human Immunodeficiency Virus 1 (HIV-1). 2023.
MLA (8th ed.) CitationIn Vitro and In Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine Against Human Immunodeficiency Virus 1 (HIV-1). 2023.
Warning: These citations may not always be 100% accurate.